Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aoxing Pharmaceutical Company Inc (AOXG)

Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Aoxing Pharmaceutical Company, Inc. is a pharmaceutical company engaged in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. It has international strategic alliances with QRxPharma Limited and American Oriental Bioengineering, Inc. in commercializing narcotic and pain management products for China and ex-China markets. The Company is working closely with the Chinese government and SFDA to assure the strictly regulated availability to medical professionals of its narcotic drugs and pain medicines throughout China. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang City, China.

Fiscal Year End Date: 06/30

(Values in U.S. Thousands) Jun, 2016 Jun, 2015 Jun, 2014 Jun, 2013 Jun, 2012
Sales 32,330 25,480 12,740 10,830 8,130
Sales Growth +26.88% +100.00% +17.64% +33.21% unch
Net Income 2,060 5,490 -8,220 -16,800 -15,820
Net Income Growth -62.48% +166.79% +51.07% -6.19% unch
(Values in U.S. Thousands) Jun, 2016 Jun, 2015 Jun, 2014 Jun, 2013 Jun, 2012
Total Assets 56,230 53,040 38,070 39,730 45,090
Total Assets Growth +6.01% +39.32% -4.18% -11.89% unch
Total Liabilities 38,160 42,980 42,080 35,150 23,820
Total Liabilities Growth -11.21% +2.14% +19.72% +47.57% unch
(Values in U.S. Thousands) Jun, 2016 Jun, 2015 Jun, 2014 Jun, 2013 Jun, 2012
Operating Cash Flow -530 3,030 -7,730 -8,320 -1,330
Operating Cash Flow Growth -117.49% +139.20% +7.09% -525.56% unch
Net Cash Flow 1,540 3,040 -1,680 330 910
Change in Net Cash Flow -49.34% +280.95% -609.09% -63.74% unch
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar